137 related articles for article (PubMed ID: 15364682)
1. Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men.
Sachdev P; Parslow R; Salonikas C; Lux O; Wen W; Kumar R; Naidoo D; Christensen H; Jorm A
Arch Neurol; 2004 Sep; 61(9):1369-76. PubMed ID: 15364682
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine, cerebrovascular disease and brain atrophy.
Sachdev P
J Neurol Sci; 2004 Nov; 226(1-2):25-9. PubMed ID: 15537514
[TBL] [Abstract][Full Text] [Related]
3. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease.
Hogervorst E; Ribeiro HM; Molyneux A; Budge M; Smith AD
Arch Neurol; 2002 May; 59(5):787-93. PubMed ID: 12020261
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people.
Dufouil C; Alpérovitch A; Ducros V; Tzourio C
Ann Neurol; 2003 Feb; 53(2):214-21. PubMed ID: 12557288
[TBL] [Abstract][Full Text] [Related]
5. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.
Sachdev PS; Valenzuela M; Wang XL; Looi JC; Brodaty H
Neurology; 2002 May; 58(10):1539-41. PubMed ID: 12034795
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample.
Sachdev PS; Anstey KJ; Parslow RA; Wen W; Maller J; Kumar R; Christensen H; Jorm AF
Dement Geriatr Cogn Disord; 2006; 21(5-6):300-8. PubMed ID: 16484809
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine and brain atrophy.
Sachdev PS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1152-61. PubMed ID: 16102882
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine as a risk factor for cognitive impairment in stroke patients.
Sachdev PS; Valenzuela MJ; Brodaty H; Wang XL; Looi J; Lorentz L; Howard L; Jones M; Zagami AS; Gillies D; Wilcken DE
Dement Geriatr Cogn Disord; 2003; 15(3):155-62. PubMed ID: 12584431
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders.
Scott TM; Tucker KL; Bhadelia A; Benjamin B; Patz S; Bhadelia R; Liebson E; Price LL; Griffith J; Rosenberg I; Folstein MF
Am J Geriatr Psychiatry; 2004; 12(6):631-8. PubMed ID: 15545331
[TBL] [Abstract][Full Text] [Related]
10. The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients.
Annerbo S; Wahlund LO; Lökk J
Dement Geriatr Cogn Disord; 2005; 20(4):209-14. PubMed ID: 16088136
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma homocysteine is associated with increased brain atrophy rates in older subjects with mild hypertension.
Narayan SK; Firbank MJ; Saxby BK; Stansby G; Hansrani M; O'Brien JT; Ford GA
Dement Geriatr Cogn Disord; 2011; 31(5):341-8. PubMed ID: 21597295
[TBL] [Abstract][Full Text] [Related]
12. Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey.
Kim G; Kim H; Kim KN; Son JI; Kim SY; Tamura T; Chang N
J Alzheimers Dis; 2013; 33(3):853-62. PubMed ID: 23042212
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease.
Wong A; Mok V; Fan YH; Lam WW; Liang KS; Wong KS
J Neurol; 2006 Apr; 253(4):441-7. PubMed ID: 16267639
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
[TBL] [Abstract][Full Text] [Related]
15. White matter hyperintensities are related to physical disability and poor motor function.
Sachdev PS; Wen W; Christensen H; Jorm AF
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):362-7. PubMed ID: 15716527
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people.
Dhonukshe-Rutten RA; Pluijm SM; de Groot LC; Lips P; Smit JH; van Staveren WA
J Bone Miner Res; 2005 Jun; 20(6):921-9. PubMed ID: 15883631
[TBL] [Abstract][Full Text] [Related]
17. White matter microstructural integrity and cognitive function in a general elderly population.
Vernooij MW; Ikram MA; Vrooman HA; Wielopolski PA; Krestin GP; Hofman A; Niessen WJ; Van der Lugt A; Breteler MM
Arch Gen Psychiatry; 2009 May; 66(5):545-53. PubMed ID: 19414714
[TBL] [Abstract][Full Text] [Related]
18. Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project.
Björck J; Hellgren M; Råstam L; Lindblad U
Metabolism; 2006 Aug; 55(8):1007-13. PubMed ID: 16839834
[TBL] [Abstract][Full Text] [Related]
19. Age dependent levels of plasma homocysteine and cognitive performance.
Agrawal A; Ilango K; Singh PK; Karmakar D; Singh GP; Kumari R; Dubey GP
Behav Brain Res; 2015 Apr; 283():139-44. PubMed ID: 25601573
[TBL] [Abstract][Full Text] [Related]
20. Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults.
Feng L; Isaac V; Sim S; Ng TP; Krishnan KR; Chee MW
Am J Geriatr Psychiatry; 2013 Feb; 21(2):164-72. PubMed ID: 23343490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
